13-cis-Acitretin
Names
[ CAS No. ]:
69427-46-9
[ Name ]:
13-cis-Acitretin
[Synonym ]:
Soriatane
9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraen-1-oic acid
9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid
(2E,4E,6E,8E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid
(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid
9-(4-Isopropyl-phenyl)-guanin
Neo-Tigasone
Acetretinate
2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (all-E)-
(all-E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid
Neotigason
2-amino-9-(4-isopropyl-phenyl)-1,9-dihydro-purin-6-one
Acitretin
2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (2E,4E,6E,8E)-
(2E,4E,6E,8E)-3,7-dimethyl-9-[2,3,6-trimethyl-4-(methyloxy)phenyl]nona-2,4,6,8-tetraenoic acid
all-trans-acitretin
SNGP-201-04-E06
Chemical & Physical Properties
[ Density]:
1.1±0.1 g/cm3
[ Boiling Point ]:
521.3±38.0 °C at 760 mmHg
[ Melting Point ]:
228-230ºC
[ Molecular Formula ]:
C21H26O3
[ Molecular Weight ]:
326.429
[ Flash Point ]:
180.3±20.3 °C
[ Exact Mass ]:
326.188202
[ PSA ]:
46.53000
[ LogP ]:
5.73
[ Vapour Pressure ]:
0.0±1.4 mmHg at 25°C
[ Index of Refraction ]:
1.570
[ Storage condition ]:
Amber Vial, -80°C Freezer
Safety Information
[ RIDADR ]:
NONH for all modes of transport
Articles
J. Am. Acad. Dermatol. 71(6) , 1167-75, (2014)
The effectiveness of psoriasis therapies in real-world settings remains relatively unknown.We sought to compare the effectiveness of less commonly used systemic therapies and commonly used combination...
Acitretin exhibits inhibitory effects towards UDP-glucuronosyltransferase (UGT)1A9-mediated 4-methylumbelliferone (4-MU) and propofol glucuronidation reaction.Pharmazie 68(6) , 449-52, (2013)
The present study aimed to evaluate the potential risk of drug-drug interactions associated with acitretin which is a drug for therapy of psoriasis approved by the Food and Drug Administration (FDA). ...
IgA pemphigus: case series with emphasis on therapeutic response.J. Am. Acad. Dermatol. 70(1) , 200-1, (2014)